Table 2.
Study | Sample source | Subject details | Methodology | Conclusion (microbiota signatures in coeliac disease) compared to controls |
---|---|---|---|---|
[78] | Stool sample | 10 Coeliac patients, 11 controls | PCR |
$Lactobacillus diversity $Lactobacillus sakei $Bifidobacterium |
[84] | Duodenal biopsy* | 10 Treated Coeliac patients with persistent symptoms, 10 treated Coeliac patients’ symptoms free | 16 S rRNA sequencing |
#Proteobacteria $Bacteroidetes $Firmicutes |
[85] | Duodenal biopsy | 6 Coeliac patients, 11 controls | 16 S rRNA sequencing |
$Bacteroidetes $Fusobacteria |
[82] | Stool sample and Duodenal biopsy | 23 Coeliac patients, 24 controls | 16S rRNA gene sequencing |
Stool sample: $Akkermanisia $Dorea Duodenal biopsy: #Helicobacter #Megasphaera |
[78] | Duodenal biopsy | 5 Coeliac Disease, 5 controls | 16S rRNA gene sequencing |
#Mycobacterium spp #Methylobacterium spp |
This table only includes the comparison of the microbial profiles in patients with active or untreated Coeliac disease and healthy controls. However, since very few studies are available in adults, we included one studya that allowed us to compare the treated coeliac patients (with persistent symptoms) with symptoms free treated Coeliac patients
#Increase in relative abundance
$Decrease in relative abundance